3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
148
Myelodysplastic Syndromes
116
Leukemia
115
Precursor Cell Lymphoblastic Leukemia-Lymphoma
95
Lymphoma
86
Lymphoma, Non-Hodgkin
80
Multiple Myeloma
74
Hodgkin Disease
68
Leukemia, Lymphocytic, Chronic, B-Cell
61
Lymphoma, Large B-Cell, Diffuse
52
Myeloproliferative Disorders
51
Congenital Abnormalities
51
Leukemia, Myeloid, Chronic-Phase
50
Lymphoma, Follicular
47
Leukemia, Myeloid, Accelerated Phase
47
Neoplasms, Plasma Cell
46
Lymphoma, Mantle-Cell
43
Leukemia, Myelomonocytic, Chronic
43
Burkitt Lymphoma
42
Lymphoma, B-Cell, Marginal Zone
41
Lymphoma, Large-Cell, Immunoblastic
39
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
39
Blast Crisis
39
Primary Myelofibrosis
36
Recurrence
33
Anemia, Refractory, with Excess of Blasts
33
Hematologic Neoplasms
32
Myelodysplastic-Myeloproliferative Diseases
31
Graft vs Host Disease
31
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
28
Interventions
fludarabine
4
fludarabine phosphate
3
Cyclophosphamide
3
thymoglobulin
1
Whole-Body Irradiation
1
Thiotepa
1
Tacrolimus
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Erythrocyte Count
1
Dexamethasone
1
Clofarabine
1
Busulfan
1
Bortezomib
1
Blood Transfusion
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thalassemia
×
Busulfan
×
Clear all
NCT00578292
2020-05-01
THALLO
Baylor College of Medicine
Phase NA
Terminated
10 enrolled
15 charts